Istituto Oncologico Veneto Irccs
Clinical trials sponsored by Istituto Oncologico Veneto Irccs, explained in plain language.
-
New attack on deadly cancer: powerful drug combo before surgery
Disease control OngoingThis study is testing whether adding an immunotherapy drug (pembrolizumab) to standard chemotherapy before surgery helps fight pleural mesothelioma more effectively. It involves 41 adults with early-stage, operable mesothelioma who haven't had prior cancer treatment. Patients rec…
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New blood test aims to spot more lung cancer clues
Diagnosis OngoingThis study is testing a new blood test to see if it can find more genetic mutations linked to lung cancer than the current standard test. It involves 130 adults with advanced lung cancer who have already had the standard test. The goal is to see if this new method is better at de…
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Virtual reality goggles aim to calm cancer patients during medical procedures
Symptom relief ENROLLING_BY_INVITATIONThis study is testing whether using virtual reality (VR) goggles during a medical procedure can help cancer patients feel less anxious and experience less pain. The procedure involves placing a special type of IV line called a PICC or a port, which is common for cancer treatment …
Phase: NA • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Symptom relief
Last updated Mar 20, 2026 14:47 UTC
-
Scientists map the immune battlefield inside deadly brain tumors
Knowledge-focused OngoingThis study aims to better understand how aggressive brain tumors (gliomas) suppress a patient's immune system. Researchers will use special MRI and PET scans on 31 adult patients with confirmed malignant glioma to look for specific immune cells and iron deposits in the tumor. The…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC